» Articles » PMID: 15895839

Bite Force Measurement in Awake Rats: a Behavioral Model for Persistent Orofacial Muscle Pain and Hyperalgesia

Overview
Journal J Orofac Pain
Date 2005 May 18
PMID 15895839
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To test the hypotheses that masseteric inflammation produces a reduction of mean bite force and success rates and that classical anti-inflammatory agents prevent inflammation-induced changes in bite force.

Methods: Rats were initially trained to produce a bite force greater than 400 g. Once the rats attained above 70% of successful responses in a 10-minute test period, the bite force required for reinforcement was increased gradually to the target force of 1.3 kg. Seven trained rats received bilateral masseteric injections of complete Freund's adjuvant (CFA; 50 microL in isotonic saline). The mean number of attempted bites, the percentage of correct responses, and the bite force measured before and 1, 2, 3, 7, 10, and 14 days following the CFA injection were compared. Five additional trained rats were injected with the same volume of vehicle control. Other rats (n = 10) were treated with anti-inflammatory agents before and after the CFA injection.

Results: Intramuscular CFA, but not the vehicle, produced a significant reduction of mean bite force and success rate at days 1, 2, and 3. Bite force and success rate gradually increased; they returned to baseline by 14 days. The CFA-mediated reduction of bite force and success rate was prevented in rats treated with anti-inflammatory agents administered intraperitoneally (dexamethasone, n = 5, or indomethacin, n = 5, 4 mg/kg).

Conclusion: These results provide further evidence that bite force measurements in awake rats can be a useful method for the study of inflammatory muscle hyperalgesia.

Citing Articles

Pain-sensorimotor interactions: New perspectives and a new model.

Murray G, Sessle B Neurobiol Pain. 2024; 15:100150.

PMID: 38327725 PMC: 10847382. DOI: 10.1016/j.ynpai.2024.100150.


Preclinical orofacial pain assays and measures and chronic primary orofacial pain research: where we are and where we need to go.

Sadighparvar S, Al-Hamed F, Sharif-Naeini R, Meloto C Front Pain Res (Lausanne). 2023; 4:1150749.

PMID: 37293433 PMC: 10244561. DOI: 10.3389/fpain.2023.1150749.


Assessing Orofacial Pain Behaviors in Animal Models: A Review.

Liu S, Crawford J, Tao F Brain Sci. 2023; 13(3).

PMID: 36979200 PMC: 10046781. DOI: 10.3390/brainsci13030390.


The degeneration-pain relationship in the temporomandibular joint: Current understandings and rodent models.

Chung M, Wang S, Alshanqiti I, Hu J, Ro J Front Pain Res (Lausanne). 2023; 4:1038808.

PMID: 36846071 PMC: 9947567. DOI: 10.3389/fpain.2023.1038808.


Sensory Neuron-TRPV4 Modulates Temporomandibular Disorder Pain Via CGRP in Mice.

Suttle A, Wang P, Dias F, Zhang Q, Luo Y, Simmons L J Pain. 2022; 24(5):782-795.

PMID: 36509176 PMC: 10164682. DOI: 10.1016/j.jpain.2022.12.001.